Krystal Biotech Inc (KRYS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Sales | 116,357 | 107,105 | 97,800 | 96,042 | 88,183 |
| Cost of Goods | 6,323 | 6,593 | 4,263 | 7,165 | 5,028 |
| Gross Profit | 110,034 | 100,512 | 93,537 | 88,877 | 83,155 |
| Operating Expenses | 56,668 | 56,743 | 52,426 | 49,735 | 46,931 |
| Operating Income | 53,689 | 44,362 | 41,374 | 39,307 | 36,252 |
| Other Income | 7,753 | 6,770 | 6,593 | 7,468 | 7,345 |
| Pre-tax Income | 61,442 | 51,132 | 47,967 | 46,775 | 43,597 |
| Income Tax | 5,510 | -268 | -31,398 | 8,442 | 7,864 |
| Net Income Continuous | 55,932 | 51,400 | 79,365 | 38,333 | 35,733 |
| Net Income | $55,932 | $51,400 | $79,365 | $38,333 | $35,733 |
| EPS Basic Total Ops | 1.91 | 1.77 | 2.74 | 1.33 | 1.24 |
| EPS Basic Continuous Ops | 1.91 | 1.77 | 2.74 | 1.33 | 1.24 |
| EPS Diluted Total Ops | 1.83 | 1.69 | 2.66 | 1.29 | 1.20 |
| EPS Diluted Continuous Ops | 1.83 | 1.69 | 2.66 | 1.29 | 1.20 |
| EPS Diluted Before Non-Recurring Items | 1.83 | 1.70 | 2.66 | 1.29 | 1.20 |
| EBITDA(a) | $55,415 | $46,124 | $42,986 | $40,850 | $37,886 |